COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,731 Articles (22,502 medRxiv, 8,229 bioRxiv)

Most recent first Previous |  Page 903: Articles 9021-9030  | Next

Comparative complete scheme and booster effectiveness of COVID-19 vaccines in preventing SARS-CoV-2 infections with SARS-CoV-2 Omicron (BA.1) and Delta (B.1.617.2) variants
Kislaya, I., PERALTA SANTOS, A., Borges, V., Vieira, L., Sousa, C., Ferreira, B., Pelerito, A., Gomes, J. P., Pinto Leite, P., Nunes, B.
10.1101/2022.01.31.22270200 — Posted: 2022-02-02
Spatial Growth Rate of Emerging SARS-CoV-2 Lineages in England, September 2020-December 2021
Smallman-Raynor, M. R., Cliff, A. D., The COVID-19 Genomics UK (COG-UK) Consortium
10.1101/2022.02.02.22270110 — Posted: 2022-02-02
A pseudotyped lentivirus-based assay to titer SARS-CoV-2 neutralizing antibodies in Mexico
Cruz-Cardenas, J. A., Gutierrez-Mayret, M., Lopez-Arredondo, A., Castaneda-Delgado, J. E., Rojas-Martinez, A., Garcia-Rivas, G., Enciso-Moreno, J. A., Palomares, L. A., Brunck, M. E. G.
10.1101/2022.01.27.478128 — Posted: 2022-02-02
An outbreak of SARS-CoV-2 in a public-facing office in England, 2021
Atkinson, B., van Veldhoven, K., Nicholls, I., Coldwell, M., Clarke, A., Frost, G., Atchison, C. J., Raja, A. I., Bennett, A. M., Morgan, D., Pearce, N., Fletcher, T., Brickley, E. B., Chen, Y.
10.1101/2022.01.31.22269194 — Posted: 2022-02-01
The course of COVID-19 in patients with chronic spontaneous urticaria receiving omalizumab treatment
ATAYIK, E., Aytekin, G.
10.1101/2022.01.29.22270077 — Posted: 2022-02-01
SARS-CoV-2 Variant Surveillance Using Tandem Targeted RT-PCR-based Genotyping Assays and Whole Genome Sequencing
Pinkhover, N. P., Sanchez, E., Pontbriand, K. M., Okello, K., Garvey, L. M., Fletcher, K. P., Pum, A., Li, K., DeOliveira, G., Proctor, T. B., Feenstra, J. D. M., Sorel, O., Gandhi, M., Auclair, J.
10.1101/2022.01.31.22270226 — Posted: 2022-02-01
Detection of prevalent SARS-CoV-2 variant lineages in wastewater and clinical sequences from cities in Quebec, Canada
N'Guessan, A., Tsitouras, A., Sanchez-Quete, F., Goitom, E., Reiling, S. J., Galvez, J. H., Nguyen, T. L., Nguyen, H. T. L., Visentin, F., Hachad, M., Krylova, K., Matthews, S., Kraemer, S. A., Stretenowich, P., Bourgey, M., Djambazian, H., Chen, S.-H., Roy, A.-M., Brookes, B., Lee, S., Simon, M.-M., Maere, T., Vanrolleghem, P., Labelle, M.-A., Moreira, S., Levade, I., Bourque, G., Ragoussis, J., Dorner, S., Frigon, D., Shapiro, B. J.
10.1101/2022.02.01.22270170 — Posted: 2022-02-01
Partnering with Athletes to Assess Risk of COVID-Related Myocarditis
Kay, B. W., Feher, A., Reinhardt, S., Cuomo, J., Arlis-Mayor, S., Lynch, M., Johnson, K., Kemp, P., Wagner, H., Welsh, T., Lamy, J., Peters, D., Mojibian, H., Young, L., Lampert, R., McNamara, R., Baldassarre, L., Miller, E. J., Spatz, E. S.
10.1101/2022.01.29.22270074 — Posted: 2022-02-01
Engineering SARS-CoV-2 cocktail antibodies into a bispecific format improves neutralizing potency and breadth
Ku, Z., Xie, X., Lin, J., Gao, P., Sahili, A. E., Su, H., Liu, Y., Ye, X., Li, X., Fan, X., Goh, B. C., Xiong, W., Boyd, H., Muruato, A. E., Deng, H., Xia, H., Jing, Z., Kalveram, B. K., Menachery, V. D., Zhang, N., Lescar, J., Shi, P.-Y., An, Z.
10.1101/2022.02.01.478504 — Posted: 2022-02-01
Influenza virus-like particle-based hybrid vaccine containing RBD induces immunity against influenza and SARS-CoV-2 viruses
Bommireddy, R., Stone, S., Bhatnagar, N., Kumari, P., Munoz, L. E., Oh, J., Kim, K.-H., Berry, J. T., Jacobsen, K., Lahcen, J., Naing, S.-H., Blackerby, A. N., Gaag, T. V. d., Wright, C. N., Lai, L., Pack, C. D., Ramachandiran, S., Suthar, M. S., Kang, S.-M., Kumar, M., Reddy, S. J., Selvaraj, P.
10.1101/2022.02.01.478657 — Posted: 2022-02-01

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).